Brain uptake of an anti-ischemic agent by nasal administration of microparticles.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Pharmacy and Science

• Publication date

  2008-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jps.21335PMID 18300305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury.

  2007cited by this paper
• Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.

  2007cited by this paper
• Primary microparticles and agglomerates of morphine for nasal insufflation.

  2006cited by this paper
• Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.

  2006cited by this paper
• Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in‐vitro/ex‐vivo studies

  2005cited by this paper
• Intranasal drug delivery for brain targeting.

  2005cited by this paper
• Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives.

  2005cited by this paper
• Transport of hydroxyzine and triprolidine across bovine olfactory mucosa: role of passive diffusion in the direct nose-to-brain uptake of small molecules.

  2005cited by this paper
• Brain penetration of synthetic adenosine A1 receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents.

  2005cited by this paper
• Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.

  2004cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Is nose‐to‐brain transport of drugs in man a reality?

  2004cited by this paper
• Chitosan chemistry and pharmaceutical perspectives.

  2004cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Caffeine microparticles for nasal administration obtained by spray drying.

  2002cited by this paper
• Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity.

  2002cited by this paper
• Intranasal delivery of morphine.

  2002cited by this paper
• Adenosine A(1) receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system.

  2002cited by this paper
• Poly(lactic acid) microspheres for the sustained release of antiischemic agents.

  2002cited by this paper
• Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles

  2002cited by this paper
• In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits.

  2002cited by this paper
• Adenosine A1 Receptor: Analysis of the Potential Therapeutic Effects Obtained by its Activation in the Central Nervous System

  2002cited by this paper
• Synthesis and Study of 5′-Ester Prodrugs of N6-Cyclopentyladenosine, a Selective A1 Receptor Agonist

  2001cited by this paper
• Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion.

  2001cited by this paper
• The biopharmaceutical aspects of nasal mucoadhesive drug delivery

  2001cited by this paper
• Levels of dopamine in blood and brain following nasal administration to rats.

  2001cited by this paper
• Delivery of Neurotrophic Factors to the Central Nervous System

  2001cited by this paper
• Poly(lactic acid) microspheres for the sustained release of a selective A1 receptor agonist.

  2001cited by this paper
• Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

  2001cited by this paper
• Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan.

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?

  2000cited by this paper
• Transporter-mediated permeation of drugs across the blood-brain barrier.

  2000cited by this paper
• Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?

  1999cited by this paper
• Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?

  1999cited by this paper
• Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.

  1999cited by this paper
• Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles

  1999cited by this paper
• Effects of physicochemical properties and other factors on systemic nasal drug delivery.

  1998cited by this paper
• Selectivity of action of 8‐alkylamino analogues of N6‐cyclopentyladenosine in vivo: haemodynamic versus anti‐lipolytic responses in rats

  1998cited by this paper
• Processing of adenosine receptor agonists in rat and human whole blood.

  1998cited by this paper
• The distribution of local anesthetics into the CSF following intranasal administration

  1998cited by this paper
• Lidocaine distribution into the CNS following nasal and arterial delivery: a comparison of local sampling and microdialysis techniques

  1998cited by this paper
• Distribution of antihistamines into the CSF following intranasal delivery.

  1997cited by this paper
• Spray-drying as a preparation method of microparticulate drug delivery systems: an overview

  1995cited by this paper
• Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats.

  1994cited by this paper
• Spray dried albumin microspheres containing nicardipine

  1994cited by this paper
• Full and partial agonistic behaviour and thermodynamic binding parameters of adenosine A1 receptor ligands.

  1994cited by this paper
• Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists.

  1994cited by this paper
• Adenosinergic modulation of CA1 neuronal tolerance to glucose deprivation in organotypic hippocampal cultures.

  1994cited by this paper
• Partial agonism of theophylline-7-riboside on adenosine receptors

  1994cited by this paper
• High-performance liquid chromatography of the adenosine A1 agonist N6-cyclopentyladenosine and the A1 antagonist 8-cyclopentyltheophylline and its application in a pharmacokinetic study in rats.

  1993cited by this paper
• The relevance of nasal physiology to the design of drug absorption studies

  1993cited by this paper
• Excitatory Transmitter Amino Acid Release from the Ischemic Rat Cerebral Cortex: Effects of Adenosine Receptor Agonists and Antagonists

  1992cited by this paper
• Intranasal Insulin

  1992cited by this paper
• In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers

  1992cited by this paper
• Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity

  1991cited by this paper
• Central versus peripheral mediation of responses to adenosine receptor agonists: evidence against a central mode of action.

  1987cited by this paper

• Uniform Spray Dried Loxapine Microparticles Potentially for Nasal Delivery: Exploring Discriminatory In Vitro Release Evaluation Methods

  2025cites this paper
• Development of Nanocomposite Microspheres for Nasal Administration of Deferiprone in Neurodegenerative Disorders

  2024cites this paper
• Supramolecular eutectogel as new oral paediatric delivery system to enhance benznidazole bioavailability.

  2024cites this paper
• A review of chitosan polysaccharides: Neuropharmacological implications and tissue regeneration.

  2024cites this paper
• Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics

  2023cites this paper
• Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles

  2023cites this paper
• Improving in vivo oral bioavailability of a poorly soluble drug: a case study on polymeric versus lipid nanoparticles

  2022cites this paper
• Spray dried powders for nasal delivery: Process and formulation considerations.

  2022cites this paper
• Advanced particulate carrier-mediated technologies for nasal drug delivery

  2022cites this paper
• Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders

  2022cites this paper
• Microspheres for targeted drug delivery- A review on recent applications

  2022cites this paper
• A comprehensive review on carrier mediated nose to brain targeting: emphasis on molecular targets, current trends, future prospects, and challenges

  2022cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Applications of nose-to-brain delivery in nanodiagnosis and nanotherapy of neurodegenerative disorders

  2021cites this paper
• Targeting Systems to the Brain Obtained by Merging Prodrugs, Nanoparticles, and Nasal Administration

  2021cites this paper
• Experimental models for evaluation of direct nose-to-brain drug delivery

  2021cites this paper
• Natural Biomaterials in Brain Repair: a Focus on Collagen.

  2021cites this paper
• Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?

  2021cites this paper
• Formulation strategies for nose-to-brain delivery of therapeutic molecules

  2020cites this paper
• Intranasal Delivering Method in the Treatment of Ischemic Stroke

  2019cites this paper
• Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration

  2019cites this paper
• Therapeutic Intranasal Delivery for Stroke and Neurological Disorders

  2019cites this paper
• Interaction Studies Between Levodopa and Different Excipients to Develop Coground Binary Mixtures for Intranasal Application.

  2019cites this paper
• An enhanced charge-driven intranasal delivery of nicardipine attenuates brain injury after intracerebral hemorrhage.

  2019cites this paper
• Therapeutic Potential of Intranasal Drug Delivery in Preclinical Studies of Ischemic Stroke and Intracerebral Hemorrhage

  2019cites this paper
• A Novel Contrast Agent Based on Magnetic Nanoparticles for Cholesterol Detection as Alzheimer’s Disease Biomarker

  2019cites this paper
• Chitosan and chitosan coating nanoparticles for the treatment of brain disease

  2019cites this paper
• Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery.

  2019cites this paper
• In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates

  2018cites this paper
• The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability

  2018cites this paper
• An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems

  2018cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper
• Challenges of the Nose-to-Brain Route

  2017cites this paper
• Progress in brain targeting drug delivery system by nasal route

  2017cites this paper
• Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.

  2017cites this paper
• Pharmaceutics, Drug Delivery and Pharmaceutical Technology Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-b-cyclodextrin on b-Amyloid (1-42)eInduced Toxicity

  2016cites this paper
• Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)-Induced Toxicity.

  2016cites this paper
• PLGA/DPPC/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment.

  2016cites this paper
• Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems.

  2016cites this paper
• Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles

  2016cites this paper
• Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review

  2016cites this paper
• Polysaccharides as drug delivery systems for different administration routes

  2016influential citation
• Influence of Dosage Form, Formulation, and Delivery Device on Olfactory Deposition and Clearance: Enhancement of Nose-to-CNS Uptake

  2015cites this paper
• From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.

  2015cites this paper
• Advances in Neurotherapeutic Delivery Technologies

  2015cites this paper
• Transport Mechanisms of Neurotherapeutics across the Blood-Brain Barrier eBooks

  2015cites this paper
• Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.

  2015cites this paper
• Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries.

  2015cites this paper
• Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders.

  2014cites this paper
• Multidrug resistance in cancer or inefficacy of neuroactive agents: innovative strategies to inhibit or circumvent the active efflux transporters selectively.

  2014cites this paper
• Nanospray Drying as a Novel Technique for the Manufacturing of Inhalable NSAID Powders

  2014cites this paper
• Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles.

  2014cites this paper
• Nanospray drying as a novel technique for the manufacturing of inhalable NSAID powders.

  2014cites this paper
• Chitosan in nasal delivery systems for therapeutic drugs.

  2014cites this paper
• The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA.

  2013cites this paper
• Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.

  2013cites this paper
• Improving treatment of stroke through nanotechnology

  2013cites this paper
• Chitosan and its derivatives as the carrier for intranasal drug delivery

  2012cites this paper
• Zidovudine and ursodeoxycholic acid conjugation: design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system.

  2012cites this paper
• Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in vivo preclinical pharmacokinetic study.

  2012cites this paper
• A novel conjugated agent between dopamine and an A2A adenosine receptor antagonist as a potential anti-Parkinson multitarget approach.

  2012cites this paper
• Intranasal administration: a prospective drug delivery route to the brain

  2012cites this paper
• Topical drug delivery using chitosan nano- and microparticles

  2012cites this paper
• Non-invasive Systemic Drug Delivery via Nasal Route: A Review

  2011cites this paper
• Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications.

  2011cites this paper
• Intranasal delivery of stem cells to the brain

  2011cites this paper
• Influence of chitosan glutamate on the in vivo intranasal absorption of rokitamycin from microspheres.

  2011cites this paper
• A review on factors affecting the design of nasal drug delivery system

  2011cites this paper
• Systemic and Mucosal Delivery of Drugs within Polymeric Microparticles Produced by Spray Drying

  2010cites this paper
• Potential of nanoparticulate drug delivery systems by intranasal administration.

  2010cites this paper
• Solid lipid microparticles for the stability enhancement of a dopamine prodrug.

  2010cites this paper
• Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles

  2010cites this paper
• Current concepts in topical therapy for chronic sinonasal disease.

  2010cites this paper
• Fabrication via a nonaqueous nanoprecipitation method, characterization and in vitro biological behavior of N(6)-cyclopentyladenosine-loaded nanoparticles.

  2009cites this paper
• Chitosan and its salts for mucosal and transmucosal delivery

  2009influential citation
• Mucoadhesive microspheres for nasal administration of cyclodextrins

  2009cites this paper
• New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration.

  2009cites this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cites this paper
• From nose to brain: understanding transport capacity and transport rate of drugs

  2008cites this paper
• 5.12 – Biological In Vitro Models for Absorption by Nonoral Routes

  2007cites this paper